Trasylol
Trasylol is a medicine authorised by Swissmedic under authorisation number 38837. The authorisation holder is Nordic Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 March 1977 and the authorisation is valid without a time limit. ATC code B02AB01 places the medicine in the group Antihemorrhagics.
| Authorisation number | 38837 |
|---|---|
| Name | Trasylol |
| Full name | Trasylol, Injektions-/Infusionslösung |
| Authorisation holder | Nordic Pharma GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | B02AB01 |
| First authorisation | 16 March 1977 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Trasylol, Injektions-/Infusionslösung | B | 16 March 1977 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 28 | 1 x 50 mL | Durchstechflasche(n) | B02AB01 | 06.06.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Trasylol authorised in Switzerland?
Yes. Trasylol is authorised by Swissmedic under authorisation number 38837, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Trasylol have?
Trasylol is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Trasylol?
The authorisation holder is Nordic Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.